Morgan Stanley’s Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant BITE.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1
Closed -$13 8162
2024
Q2
$13 Hold
1
﹤0.01% 7773
2024
Q1
$10 Sell
1
-1
-50% -$11 ﹤0.01% 7769
2023
Q4
$20 Buy
+2
New +$21 ﹤0.01% 7758
2022
Q1
Sell
-111
Closed -$1K 8190
2021
Q4
$1K Hold
111
﹤0.01% 7899
2021
Q3
$1K Hold
111
﹤0.01% 7823
2021
Q2
$1K Sell
111
-13
-10% -$130 ﹤0.01% 7648
2021
Q1
$1K Buy
+124
New +$1.25K ﹤0.01% 7396

Morgan Stanley's BITE.U Position: Q3 2024 in Review

Morgan Stanley sold out of Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant (BITE.U) in Q3 2024, closing a stake of 1 share — an estimated $13 sold.

Morgan Stanley first reported a position in BITE.U in Q1 2021 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 0 funds tracked by Wall St. Rank hold BITE.U as of Q3 2024.

  • Morgan Stanley reported no remaining Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 1 Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant share in Q3 2024, an estimated $13.
  • Morgan Stanley first reported a position in Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • Morgan Stanley's Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant position peaked at $1K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.